Completed PHASE3 INTERVENTIONAL 1-arm NCT01722396

Pharmacogenetics of Vitamin D Supplementation in Tuberculosis

The Pharmacogenetics of Vitamin D Supplementation in Tuberculosis

Sponsor: Heart of England NHS Trust

Interventions Vitamin D

Updated 6 times since 2017 Last updated: Jan 14, 2013 Started: Mar 31, 2011 Primary completion: Nov 30, 2012 Completion: Nov 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Tuberculosis and is currently completed. Heart of England NHS Trust leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Heart of England NHS Trust
University of Birmingham

Data source: University of Birmingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Birmingham, United Kingdom